Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1992;86:774-779

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horner, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horner, S. M.

Circulation, Vol 86, 774-779, Copyright © 1992 by American Heart Association


ARTICLES

Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction

SM Horner
Department of Cardiology, Middlesex Hospital, London, UK.

BACKGROUND. To ascertain the effect of the intravenous administration of magnesium in acute myocardial infarction on the frequency of arrhythmias and mortality, a meta-analysis of randomized controlled trials was performed. METHODS AND RESULTS. The study included 930 patients with acute myocardial infarction admitted to primary referral hospitals. Administration of magnesium in acute myocardial infarction was associated with a 49% reduction in ventricular tachycardia and fibrillation. The incidence of cardiac arrest was reduced by 58%. The frequency of supraventricular tachycardias was also lower. Overall, there was a 54% reduction in mortality. CONCLUSIONS. Intravenous magnesium is a safe and effective method of reducing the frequency of arrhythmias and mortality in acute myocardial infarction.


This article has been cited by other articles:


Home page
CirculationHome page
S. E. Lehnart, X. H.T. Wehrens, P. J. Laitinen, S. R. Reiken, S.-X. Deng, Z. Cheng, D. W. Landry, K. Kontula, H. Swan, and A. R. Marks
Sudden Death in Familial Polymorphic Ventricular Tachycardia Associated With Calcium Release Channel (Ryanodine Receptor) Leak
Circulation, June 29, 2004; 109(25): 3208 - 3214.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Amighi, S. Sabeti, O. Schlager, W. Mlekusch, M. Exner, W. Lalouschek, R. Ahmadi, E. Minar, and M. Schillinger
Low Serum Magnesium Predicts Neurological Events in Patients With Advanced Atherosclerosis
Stroke, January 1, 2004; 35(1): 22 - 27.
[Abstract] [Full Text] [PDF]


Home page
Emerg. Med. J.Home page
T B Hassan, C Jagger, and D B Barnett
A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation
Emerg. Med. J., January 1, 2002; 19(1): 57 - 62.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
I. Sim and M. A Hlatky
Growing pains of meta-analysis
BMJ, September 21, 1996; 313(7059): 702 - 703.
[Full Text]


Home page
CirculationHome page
W. R. Herzog, M. L. Schlossberg, K. S. MacMurdy, L. R. Edenbaum, M. J. Gerber, R. A. Vogel, and V. L. Serebruany
Timing of Magnesium Therapy Affects Experimental Infarct Size
Circulation, November 1, 1995; 92(9): 2622 - 2626.
[Abstract] [Full Text]


Home page
DTBHome page
Magnesium, myocardial infarction, meta-analysis and megatrials
DTB, April 1, 1995; 33(4): 25 - 27.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Caspi, E. Rudis, I. Bar, T. Safadi, and M. Saute
Effects of Magnesium on Myocardial Function After Coronary Artery Bypass Grafting
Ann. Thorac. Surg., April 1, 1995; 59(4): 942 - 947.
[Abstract] [Full Text]